Planned, ongoing and completed tuberculosis treatment trials in Brazil, Russia, India, China and South Africa: a 2019 cross-sectional descriptive analysis.

Lindi MathebulaLovemore MapahlaDilyara NurkhametovaLiliya Eugenevna ZiganshinaMikateko MazinuEsme JordanDuduzile Edith Ndwandwe Tamara Kredo

Published in: BMJ open (2022)

TB trials conducted in BRICS countries are collaborative, mostly drug treatment oriented, potentially affecting policies. Selective outcome reporting remains a problem both for prospectively and retrospectively registered trials, only small fraction of which gets to publication.

Keyphrases

south africa
mycobacterium tuberculosis
public health
adverse drug
hepatitis c virus
quality improvement
replacement therapy
pulmonary tuberculosis
hiv infected
drug induced
data analysis